Same Indication

Ipilimumab vs Spironolactone

Ipilimumab vs Spironolactone: Overview

This comparison examines the pharmacological differences between Ipilimumab and Spironolactone.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Spironolactone: Mineralocorticoid receptor antagonist.

Pharmacokinetics

Half-life: Ipilimumab — 14.7 days; Spironolactone — 1.4 hours.

Chemical Properties

Molecular Formula: Spironolactone — C24H32O4S.

Molecular Weight: Spironolactone — 416.5740 g/mol.

Type: Ipilimumab — Antibody; Spironolactone — Small molecule.